Logo image of 1FRE.MI

FRESENIUS SE & CO KGAA (1FRE.MI) Stock Fundamental Analysis

BIT:1FRE - DE0005785604 - Common Stock

47.36 EUR
+6.47 (+15.82%)
Last: 9/4/2025, 7:00:00 PM
Fundamental Rating

4

1FRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. 1FRE has an average financial health and profitability rating. 1FRE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

1FRE had positive earnings in the past year.
In the past year 1FRE had a positive cash flow from operations.
1FRE had positive earnings in 4 of the past 5 years.
Each year in the past 5 years 1FRE had a positive operating cash flow.
1FRE.MI Yearly Net Income VS EBIT VS OCF VS FCF1FRE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

With a Return On Assets value of 0.98%, 1FRE is not doing good in the industry: 70.37% of the companies in the same industry are doing better.
With a Return On Equity value of 2.17%, 1FRE is not doing good in the industry: 74.07% of the companies in the same industry are doing better.
1FRE has a Return On Invested Capital (4.04%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for 1FRE is below the industry average of 6.10%.
The last Return On Invested Capital (4.04%) for 1FRE is above the 3 year average (2.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.98%
ROE 2.17%
ROIC 4.04%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)2.76%
ROIC(5y)3.92%
1FRE.MI Yearly ROA, ROE, ROIC1FRE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

The Profit Margin of 1FRE (1.91%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of 1FRE has declined.
Looking at the Operating Margin, with a value of 8.68%, 1FRE is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
1FRE's Operating Margin has declined in the last couple of years.
The Gross Margin of 1FRE (24.48%) is comparable to the rest of the industry.
1FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.68%
PM (TTM) 1.91%
GM 24.48%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
1FRE.MI Yearly Profit, Operating, Gross Margins1FRE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

1FRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
1FRE has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1FRE has more shares outstanding
Compared to 1 year ago, 1FRE has an improved debt to assets ratio.
1FRE.MI Yearly Shares Outstanding1FRE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1FRE.MI Yearly Total Debt VS Total Assets1FRE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

1FRE has an Altman-Z score of 2.03. This is not the best score and indicates that 1FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of 1FRE (2.03) is comparable to the rest of the industry.
The Debt to FCF ratio of 1FRE is 8.76, which is on the high side as it means it would take 1FRE, 8.76 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1FRE (8.76) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.62 indicates that 1FRE is somewhat dependend on debt financing.
The Debt to Equity ratio of 1FRE (0.62) is better than 70.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.76
Altman-Z 2.03
ROIC/WACC0.74
WACC5.46%
1FRE.MI Yearly LT Debt VS Equity VS FCF1FRE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 1.43 indicates that 1FRE should not have too much problems paying its short term obligations.
The Current ratio of 1FRE (1.43) is better than 66.67% of its industry peers.
1FRE has a Quick Ratio of 1.11. This is a normal value and indicates that 1FRE is financially healthy and should not expect problems in meeting its short term obligations.
1FRE's Quick ratio of 1.11 is fine compared to the rest of the industry. 1FRE outperforms 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.11
1FRE.MI Yearly Current Assets VS Current Liabilites1FRE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

1FRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 785.11%, which is quite impressive.
1FRE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.29% yearly.
1FRE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.12%.
The Revenue has been decreasing by -9.22% on average over the past years.
EPS 1Y (TTM)785.11%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%31.34%
Revenue 1Y (TTM)-20.12%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%-0.93%

3.2 Future

Based on estimates for the next years, 1FRE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.10% on average per year.
Based on estimates for the next years, 1FRE will show a small growth in Revenue. The Revenue will grow by 4.98% on average per year.
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y10.1%
Revenue Next Year4.95%
Revenue Next 2Y4.99%
Revenue Next 3Y5.02%
Revenue Next 5Y4.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1FRE.MI Yearly Revenue VS Estimates1FRE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B 40B
1FRE.MI Yearly EPS VS Estimates1FRE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.71, the valuation of 1FRE can be described as correct.
Based on the Price/Earnings ratio, 1FRE is valued a bit cheaper than 62.96% of the companies in the same industry.
1FRE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.07.
1FRE is valuated correctly with a Price/Forward Earnings ratio of 12.78.
70.37% of the companies in the same industry are more expensive than 1FRE, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.59. 1FRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.71
Fwd PE 12.78
1FRE.MI Price Earnings VS Forward Price Earnings1FRE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

1FRE's Enterprise Value to EBITDA ratio is in line with the industry average.
1FRE's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 1FRE is more expensive than 62.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.17
EV/EBITDA 11.02
1FRE.MI Per share data1FRE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.46
PEG (5Y)N/A
EPS Next 2Y10.97%
EPS Next 3Y9.91%

4

5. Dividend

5.1 Amount

1FRE has a Yearly Dividend Yield of 2.37%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.78, 1FRE pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.46, 1FRE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.37%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1FRE pays out 22.75% of its income as dividend. This is a sustainable payout ratio.
DP22.75%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
1FRE.MI Yearly Income VS Free CF VS Dividend1FRE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
1FRE.MI Dividend Payout.1FRE.MI Dividend Payout, showing the Payout Ratio.1FRE.MI Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

BIT:1FRE (9/4/2025, 7:00:00 PM)

47.36

+6.47 (+15.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners36.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.68B
Analysts83.48
Price Target49.8 (5.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.37%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP22.75%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.13%
Min EPS beat(2)12.64%
Max EPS beat(2)17.61%
EPS beat(4)3
Avg EPS beat(4)8.93%
Min EPS beat(4)-3.48%
Max EPS beat(4)17.61%
EPS beat(8)4
Avg EPS beat(8)-53.43%
EPS beat(12)5
Avg EPS beat(12)-43.42%
EPS beat(16)8
Avg EPS beat(16)-32.16%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)2.4%
Max Revenue beat(2)2.84%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)0.8%
Revenue beat(12)5
Avg Revenue beat(12)0.35%
Revenue beat(16)7
Avg Revenue beat(16)0.43%
PT rev (1m)2.28%
PT rev (3m)7.91%
EPS NQ rev (1m)7.18%
EPS NQ rev (3m)-0.25%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE 14.71
Fwd PE 12.78
P/S 1.21
P/FCF 17.17
P/OCF 10.85
P/B 1.37
P/tB 12.36
EV/EBITDA 11.02
EPS(TTM)3.22
EY6.8%
EPS(NY)3.71
Fwd EY7.83%
FCF(TTM)2.76
FCFY5.83%
OCF(TTM)4.37
OCFY9.22%
SpS39.25
BVpS34.46
TBVpS3.83
PEG (NY)1.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 2.17%
ROCE 5.5%
ROIC 4.04%
ROICexc 4.55%
ROICexgc 10%
OM 8.68%
PM (TTM) 1.91%
GM 24.48%
FCFM 7.03%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)2.76%
ROIC(5y)3.92%
ROICexc(3y)2.76%
ROICexc(5y)3.98%
ROICexgc(3y)5.56%
ROICexgc(5y)8.77%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexcg growth 3Y-17.75%
ROICexcg growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.76
Debt/EBITDA 3.91
Cap/Depr 77.02%
Cap/Sales 4.09%
Interest Coverage 4.28
Cash Conversion 79.5%
Profit Quality 368.25%
Current Ratio 1.43
Quick Ratio 1.11
Altman-Z 2.03
F-Score7
WACC5.46%
ROIC/WACC0.74
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)785.11%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%31.34%
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-20.12%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%-0.93%
Revenue Next Year4.95%
Revenue Next 2Y4.99%
Revenue Next 3Y5.02%
Revenue Next 5Y4.98%
EBIT growth 1Y9.47%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.74%
EBIT Next 3Y23.83%
EBIT Next 5Y16.02%
FCF growth 1Y-34.12%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-42.44%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%